PER
Click for more information
1.25% 7.9¢ percheron therapeutics limited

Ann: US FDA Type C Meeting for ATL1102 in DMD, page-37

  1. Akki
    35,707 Posts.
    lightbulb Created with Sketch. 552
    clock Created with Sketch.
    23/04/21
    11:55
    Post #: 52676675
    As part of its Type C meeting, the Company is requesting that the FDA consider allowing the data from previously conducted 6-month monkey toxicity studies, and recently obtained 6-month (24 weeks of dosing) clinical safety data in non-ambulant DMD patients, to support the longer term (12-month) dosing of ATL1102 in DMD patients in the US.
    ANP Price at posting: 21.5¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NIM Nimy to raise $1.21M to explore 'newsy' WA targets
right-arrow Created with Sketch.
NEWS AI stocks: What to expect in 2024-25
right-arrow Created with Sketch.
NEWS Almonty locks in govt agreement for tungsten oxide plant in South Korea
right-arrow Created with Sketch.
BHP BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning
right-arrow Created with Sketch.
NEWS Bitcoin investors need to know the risks
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.9¢ 		Change
-0.001(1.25%) 		Mkt cap ! $71.22M
Open High Low Value Volume
7.9¢ 7.9¢ 7.9¢ $7.9K 100K

Buyers (Bids)

No. Vol. Price($)
3 69319 7.9¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 60863 2
View Market Depth
Last trade - 10.32am 16/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.